type here...

CATEGORIES

Editors Choice

LATEST

1...777879...157Page 78 of 157

TRENDING

EDITORS CHOICE

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Robert Turner, Founding Editor -
Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

The AMA Recognized Obesity as a Disease in 2013. How Far Have We Come in the Last 10 Years, and Where Are We Headed?

Katherine Saunders, MD -
This month marks the 10th anniversary of the American Medical Association’s decision to recognize obesity as a disease. As we reflect on this milestone,...

Nine in 10 ESG Practitioners See Strong Reporting as a Competitive Advantage

Christopher Nial -
According to a recent survey conducted with ESG professionals, a staggering 90% of respondents believe that strong reporting and data management can significantly boost competitiveness.

The Evolving Landscape of Anti-Obesity Drugs

Christopher Nial -
Obesity has become a global health crisis, with an estimated 16% of the world’s adult population classified as obese. The search for effective treatments is more urgent than ever.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories